Oliver's mTOR Atlas Evidence Platform
Reading level
Mode

Jing Zhou

Researcher in Luis Parada's lab whose work includes the 2009 study showing that rapamycin prevents and reverses brain abnormalities in neural Pten-knockout mice

UT Southwestern Medical Center, Parada lab · Pten/mTORC1 neurodevelopmental biology, 2005–2013

Jing Zhou was a fixture of Luis F. Parada's lab at UT Southwestern for roughly eight years (2005-2013), co-authoring a remarkable run of the lab's flagship papers on PTEN and mTORC1 signaling in the nervous system — across Neuron, Genes & Development, the Journal of Neuroscience, Nature Cell Biology, Human Molecular Genetics and PNAS. The 2009 J Neurosci paper in this Atlas entry showed that pharmacological inhibition of mTORC1 (rapamycin) suppressed anatomical, cellular, and behavioral abnormalities caused by neural Pten deletion in mice — evidence that mTORC1 hyperactivity underlies the neuronal hypertrophy and part of the behavioural phenotype, and a rationale for mTOR inhibitors in PTEN-related neurodevelopmental disorders.

The breadth of her authorship across the lab's genetic mouse models suggests a long-term research scientist role. Her PubMed trail as 'Jing Zhou' effectively ends with a 2013 PNAS paper; given how common this name is, her subsequent career could not be reliably traced.

Milestones in the Atlas

YearEvidenceStudy
2009 A Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice ZHO2009 First author of the paper showing pharmacological mTORC1 inhibition (rapamycin) reverses anatomical, cellular, and behavioral abnormalities in neural Pten-knockout mice.

Every researcher with a profile →

← All researchers